Alzheimer's disease: targeting the cholinergic system
TH Ferreira-Vieira, IM Guimaraes… - Current …, 2016 - ingentaconnect.com
Acetylcholine (ACh) has a crucial role in the peripheral and central nervous systems. The
enzyme choline acetyltransferase (ChAT) is responsible for synthesizing ACh from acetyl …
enzyme choline acetyltransferase (ChAT) is responsible for synthesizing ACh from acetyl …
Reimagining cholinergic therapy for Alzheimer's disease
E Giacobini, AC Cuello, A Fisher - Brain, 2022 - academic.oup.com
Currently, enhancement of cholinergic neurotransmission via cholinesterase inhibitors
represents the main available approach to treat cognitive and behavioural symptoms of the …
represents the main available approach to treat cognitive and behavioural symptoms of the …
Revisiting the cholinergic hypothesis in Alzheimer's disease: emerging evidence from translational and clinical research
Scientific evidence collected over the past 4 decades suggests that a loss of cholinergic
innervation in the cerebral cortex of patients with Alzheimer's disease is an early pathogenic …
innervation in the cerebral cortex of patients with Alzheimer's disease is an early pathogenic …
[HTML][HTML] The involvement of BDNF, NGF and GDNF in aging and Alzheimer's disease
Aging is a normal physiological process accompanied by cognitive decline. This aging
process has been the primary risk factor for development of aging-related diseases such as …
process has been the primary risk factor for development of aging-related diseases such as …
GDNF, NGF and BDNF as therapeutic options for neurodegeneration
SJ Allen, JJ Watson, DK Shoemark, NU Barua… - Pharmacology & …, 2013 - Elsevier
Glial cell-derived neurotrophic factor (GDNF), and the neurotrophin nerve growth factor
(NGF) and brain-derived neurotrophic factor (BDNF) are important for the survival …
(NGF) and brain-derived neurotrophic factor (BDNF) are important for the survival …
The cholinergic system in aging and neuronal degeneration
R Schliebs, T Arendt - Behavioural brain research, 2011 - Elsevier
The basal forebrain cholinergic complex comprising medial septum, horizontal and vertical
diagonal band of Broca, and nucleus basalis of Meynert provides the mayor cholinergic …
diagonal band of Broca, and nucleus basalis of Meynert provides the mayor cholinergic …
Alzheimer's disease: clinical trials and drug development
F Mangialasche, A Solomon, B Winblad… - The Lancet …, 2010 - thelancet.com
Alzheimer's disease is the most common cause of dementia in elderly people. Research into
Alzheimer's disease therapy has been at least partly successful in terms of developing …
Alzheimer's disease therapy has been at least partly successful in terms of developing …
Potential therapeutic uses of BDNF in neurological and psychiatric disorders
AH Nagahara, MH Tuszynski - Nature reviews Drug discovery, 2011 - nature.com
The growth factor brain-derived neurotrophic factor (BDNF) and its receptor tropomyosin-
related kinase receptor type B (TRKB) are actively produced and trafficked in multiple …
related kinase receptor type B (TRKB) are actively produced and trafficked in multiple …
Neurotrophins and their receptors: a convergence point for many signalling pathways
MV Chao - Nature Reviews Neuroscience, 2003 - nature.com
The neurotrophins are a family of proteins that are essential for the development of the
vertebrate nervous system. Each neurotrophin can signal through two different types of cell …
vertebrate nervous system. Each neurotrophin can signal through two different types of cell …
[HTML][HTML] Alzheimer disease
RJ Castellani, RK Rolston, MA Smith - Disease-a-month: DM, 2010 - ncbi.nlm.nih.gov
In 1907, Alois Alzheimer described the case of a 51 year old woman who presented with a
relatively rapidly deteriorating memory along with psychiatric disturbances. She died four …
relatively rapidly deteriorating memory along with psychiatric disturbances. She died four …